Scientific article
Open access

Prognostic value of imaging-based ATN profiles in a memory clinic cohort

Published inEuropean journal of nuclear medicine and molecular imaging, vol. 50, no. 11, p. 3313-3323
Publication date2023-09
First online date2023-06-26

Purpose: The ATN model represents a research framework used to classify subjects based on the presence or absence of Alzheimer's disease (AD) pathology through biomarkers for amyloid (A), tau (T), and neurodegeneration (N). The aim of this study was to assess the relationship between ATN profiles defined through imaging and cognitive decline in a memory clinic cohort.

Methods: One hundred-eight patients from the memory clinic of Geneva University Hospitals underwent complete clinical and neuropsychological evaluation at baseline and 23 ± 5 months after inclusion, magnetic resonance imaging, amyloid and tau PET scans. ATN profiles were divided into four groups: normal, AD pathological change (AD-PC: A + T-N-, A + T-N +), AD pathology (AD-P: A + T + N-, A + T + N +), and suspected non-AD pathology (SNAP: A-T + N-, A-T-N + , A-T + N +).

Results: Mini-Mental State Examination (MMSE) scores were significantly different among groups, both at baseline and follow-up, with the normal group having higher average MMSE scores than the other groups. MMSE scores changed significantly after 2 years only in AD-PC and AD-P groups. AD-P profile classification also had the largest number of decliners at follow-up (55%) and the steepest global cognitive decline compared to the normal group. Cox regression showed that participants within the AD-P group had a higher risk of cognitive decline (HR = 6.15, CI = 2.59-14.59), followed by AD-PC (HR = 3.16, CI = 1.17-8.52).

Conclusion: Of the different group classifications, AD-P was found to have the most significant effect on cognitive decline over a period of 2 years, highlighting the value of both amyloid and tau PET molecular imaging as prognostic imaging biomarkers in clinical practice.

  • ATN profile
  • Alzheimer’s disease
  • Cognitive decline
  • Positron emission tomography
  • Humans
  • Prognosis
  • Amyloid beta-Peptides
  • tau Proteins
  • Alzheimer Disease / diagnostic imaging
  • Cognitive Dysfunction / diagnostic imaging
  • Cognitive Dysfunction / pathology
  • Biomarkers
  • Positron-Emission Tomography
Citation (ISO format)
PERETTI, Debora et al. Prognostic value of imaging-based ATN profiles in a memory clinic cohort. In: European journal of nuclear medicine and molecular imaging, 2023, vol. 50, n° 11, p. 3313–3323. doi: 10.1007/s00259-023-06311-3
Main files (1)
Article (Published version)
Secondary files (1)
ISSN of the journal1619-7070

Technical informations

Creation05/03/2024 1:12:06 PM
First validation05/07/2024 11:09:17 AM
Update time05/07/2024 11:09:17 AM
Status update05/07/2024 11:09:17 AM
Last indexation05/07/2024 11:09:37 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack